封面
市場調查報告書
商品編碼
1490082

幹細胞銀行市場:依來源類型、依服務類型、依應用、按地區

Stem Cell Banking Market, By Source Type, By Service Type, By Application, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 148 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2024年全球幹細胞銀行市場規模為56.7億美元,2031年將達到146.4億美元,2024年至2031年的年複合成長率為14.5%。

報告範圍 報告詳情
基準年 2023年 2024年市場規模 56.7億美元
實際資料 2019-2023 預測期 2024年至2031年
預測 2024-2031 年年複合成長率: 14.50% 2031年價值預測 146.4億美元
圖:2024 年按地區分類的幹細胞銀行市場佔有率(%)
幹細胞銀行市場-IMG1

幹細胞是未分化的活細胞,可以分化為體內的特殊細胞。如果捐贈者或其家人需要的話,儲存這些幹細胞有助於保存和存檔以供將來的治療用途。人們對幹細胞療法治療癌症和血液疾病等慢性疾病的認知不斷增強,這推動了對幹細胞庫的需求。對女性健康日益成長的興趣以及社會對幹細胞研究日益成長的興趣預計將推動市場成長。然而,採集和儲存幹細胞的高成本可能會阻礙市場成長。科學技術的進步預計將在不久的將來推動幹細胞銀行的創新。

市場動態:

全球幹細胞銀行市場的成長主要是由癌症和血液疾病等危及生命的慢性疾病的增加所推動的。幹細胞療法為此類疾病提供了一種潛在的替代療法。增加公共和私人投資以鼓勵世界各地的幹細胞研究活動也推動了市場成長。人們對保留生育能力和提高幹細胞移植成功率的女性健康越來越感興趣,正在推動幹細胞庫的採用。然而,提取、加工、儲存和運輸的高昂成本可能會阻礙市場成長。政府和私人機構不斷提高宣傳宣傳活動,以促進分娩期間的臍帶血儲存,也為市場成長創造了新的機會。市場開拓正在投資研發,以開發更好的幹細胞處理和保存技術。

本研究的主要特點

  • 本報告對全球幹細胞銀行市場進行了詳細分析,並提供了以2023年為基準年的預測期(2024-2031年)的市場規模(十億美元)和年複合成長率(CAGR%)。
  • 它還強調了各個細分市場的潛在收益成長機會,並說明了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 本文根據公司亮點、產品系列、主要亮點、績效和策略等參數,介紹了全球幹細胞銀行市場的主要企業。
  • 主要企業包括 Stem Cyte, Inc.、CRYO-CELL INTERNATIONAL, INC.、ViaCord、Cord Blood Registration、SmartCells, Inc.、LifeCell International Pvt. Ltd.、Cryoviva Biotech Pvt. Ltd.、Cryo Stemcell 和 Reliance Life Sciences。 Transcell Biolife Pvt. Ltd.、Cordlife Group Limited、Covis Pharma 和CSG Bio。
  • 從這份報告中獲得的見解將幫助負責人和公司經營團隊就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 全球幹細胞銀行市場迎合該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 透過用於分析全球幹細胞銀行市場的各種策略矩陣,將有助於相關人員做出決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管場景
  • 流行病學
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第4章全球幹細胞銀行市場 - 冠狀病毒(COVID-19)大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 對市場的影響

第5章 全球幹細胞銀行市場,依來源類型,2019-2031

  • 臍帶幹細胞
  • 臍帶血
  • 臍帶組織
  • 胎盤
  • 成體幹細胞
  • 胚胎幹細胞

第6章 全球幹細胞銀行市場,依服務類型,2019-2031

  • 收集及運輸
  • 流程
  • 分析
  • 貯存

第7章 全球幹細胞銀行市場,依應用分類,2019-2031

  • 白血病
  • 糖尿病
  • 淋巴瘤
  • 腦性麻痹
  • 地中海型貧血
  • 其他

第8章全球幹細胞銀行市場,按地區,2019-2031

第9章 競爭格局

  • 公司簡介
    • Stem Cyte, Inc.
    • CRYO-CELL INTERNATIONAL, INC.
    • ViaCord
    • Cord Blood Registry
    • SmartCells, Inc.
    • LifeCell International Pvt. Ltd.
    • Cryoviva Biotech Pvt. Ltd.
    • Cryo Stemcell
    • Reliance Life Sciences
    • Transcell Biolife Pvt. Ltd.
    • Cordlife Group Limited
    • Covis Pharma
    • CSG Bio

第10章分析師建議

  • Wheel of Fortune
  • 分析師觀點
  • Coherent Opportunity Map

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1354

Global stem cell banking market is estimated to be valued at USD 5.67 Bn in 2024 and is expected to reach USD 14.64 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.5% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 5.67 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 14.50% 2031 Value Projection: US$ 14.64 Bn
Figure. Stem Cell Banking Market Share (%), By Region, 2024
Stem Cell Banking Market - IMG1

Stem cells are undifferentiated biological cells that are capable of differentiating into specialized cell types in the body. Banking these stem cells facilitates their storage and preservation for future therapeutic use, when required by the donor or related family members. Growing awareness about stem cell therapies for treating chronic conditions such as cancer and blood disorders has boosted demand for stem cell banking. Increasing focus on women's health and rising public interest in stem cell research are expected to drive the market growth. However, high costs associated with stem cell collection and storage procedures may hamper the market growth. Scientific and technological advancements are expected to drive more innovation in stem cell banking in the near future.

Market Dynamics:

Global stem cell banking market growth is primarily driven by rising prevalence of life-threatening chronic diseases like cancer and blood disorders. Stem cell therapies offer potential treatment alternatives for such conditions. Increasing public-private investments to encourage stem cell research activities around the world also drives the market growth. Growing women's health concerns regarding fertility preservation and rising success rates of stem cell transplants boosts adoption of stem cell banking. However, high costs of collection, processing, storage, and transportation procedures can hamper the market growth. Rising awareness campaigns by government and private agencies to promote cord blood banking at childbirth also presents new opportunities for market growth. Market players are investing in R&D to develop improved stem cell processing and storage technologies.

Key Features of the Study:

  • This report provides an in-depth analysis of the global stem cell banking market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global stem cell banking market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Stem Cyte, Inc., CRYO-CELL INTERNATIONAL, INC., ViaCord, Cord Blood Registry, SmartCells, Inc., LifeCell International Pvt. Ltd., Cryoviva Biotech Pvt. Ltd., Cryo Stemcell, Reliance Life Sciences, Transcell Biolife Pvt. Ltd., Cordlife Group Limited, Covis Pharma, CSG Bio.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global stem cell banking market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell banking market.

Detailed Segmentation-

  • By Source Type:
    • Umbilical Cord Stem Cell
    • Cord Blood
    • Cord Tissue
    • Placenta
    • Adult Stem Cell
    • Embryonic Stem Cell
  • By Service Type:
    • Collection and Transportation
    • Processing
    • Analysis
    • Storage
  • By Application:
    • Leukemia
    • Diabetes
    • Lymphoma
    • Cerebral Palsy
    • Thalassemia
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Stem Cyte, Inc.
    • CRYO-CELL INTERNATIONAL, INC.
    • ViaCord
    • Cord Blood Registry
    • SmartCells, Inc.
    • LifeCell International Pvt. Ltd.
    • Cryoviva Biotech Pvt. Ltd.
    • Cryo Stemcell
    • Reliance Life Sciences
    • Transcell Biolife Pvt. Ltd.
    • Cordlife Group Limited
    • Covis Pharma
    • CSG Bio

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Source Type
    • Market Snapshot, By Service Type
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Epidemiology
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Stem Cell Banking Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Stem Cell Banking Market, By Source Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Umbilical Cord Stem Cell
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cord Blood
  • Cord Tissue
  • Placenta
  • Adult Stem Cell
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Embryonic Stem Cell
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Stem Cell Banking Market, By Service Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Collection and Transportation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Processing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Analysis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Storage
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Stem Cell Banking Market, By Application, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Leukemia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Diabetes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Lymphoma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cerebral Palsy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Thalassemia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Stem Cell Banking Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Stem Cyte, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • CRYO-CELL INTERNATIONAL, INC.
    • ViaCord
    • Cord Blood Registry
    • SmartCells, Inc.
    • LifeCell International Pvt. Ltd.
    • Cryoviva Biotech Pvt. Ltd.
    • Cryo Stemcell
    • Reliance Life Sciences
    • Transcell Biolife Pvt. Ltd.
    • Cordlife Group Limited
    • Covis Pharma
    • CSG Bio

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact